Multi-omic, Single-Cell, and Biochemical Profiles of Astronauts Guide Pharmacological Strategies for Returning to Gravity

The National Aeronautics and Space Administration (NASA) Twins Study created an integrative molecular profile of an astronaut during NASA’s first 1-year mission on the International Space Station (ISS) and included comparisons to an identical Earth-bound twin. The unique biochemical profiles observe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell reports (Cambridge) 2020-12, Vol.33 (10), p.108429-108429, Article 108429
Hauptverfasser: Gertz, Monica L., Chin, Christopher R., Tomoiaga, Delia, MacKay, Matthew, Chang, Christina, Butler, Daniel, Afshinnekoo, Ebrahim, Bezdan, Daniela, Schmidt, Michael A., Mozsary, Christopher, Melnick, Ari, Garrett-Bakelman, Francine, Crucian, Brian, Lee, Stuart M.C., Zwart, Sara R., Smith, Scott M., Meydan, Cem, Mason, Christopher E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The National Aeronautics and Space Administration (NASA) Twins Study created an integrative molecular profile of an astronaut during NASA’s first 1-year mission on the International Space Station (ISS) and included comparisons to an identical Earth-bound twin. The unique biochemical profiles observed when landing on Earth after such a long mission (e.g., spikes in interleukin-1 [IL-1]/6/10, c-reactive protein [CRP], C-C motif chemokine ligand 2 [CCL2], IL-1 receptor antagonist [IL-1ra], and tumor necrosis factor alpha [TNF-α]) opened new questions about the human body’s response to gravity and how to plan for future astronauts, particularly around initiation or resolution of inflammation. Here, single-cell, multi-omic (100-plex epitope profile and gene expression) profiling of peripheral blood mononuclear cells (PBMCs) showed changes to blood cell composition and gene expression post-flight, specifically for monocytes and dendritic cell precursors. These were consistent with flight-induced cytokine and immune system stress, followed by skeletal muscle regeneration in response to gravity. Finally, we examined these profiles relative to 6-month missions in 28 other astronauts and detail potential pharmacological interventions for returning to gravity in future missions. [Display omitted] •IL-6, IL-10, IL-1ra, CCL2, and CRP rose significantly on landing after a year in space•IL-6 and IL-1ra are potential targets for pharmacological intervention in astronauts•These cytokines are also associated with muscle regeneration in response to gravity•Muscle-generated IL-6 drives classic signaling cascades in an anti-inflammatory role Gertz et al. present a re-analysis of the landing data from the NASA Twins Study, suggesting that the biochemical signature reflects muscle regeneration after atrophy rather than a detrimental inflammatory response. This is mediated through muscle-derived IL-6 anti-inflammatory cascades. Single-cell analysis supports this role. Potential pharmacological interventions are also discussed.
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2020.108429